IP Library Granted Patent US 11,071,801
Granted Patent B2
US 11,071,801 · App. 15/433,510 · Granted Jul 27, 2021

Release of ClO

Inventors: Nicholas Abbott (Madison, WI); Rishabh Jain (Appleton, WI); Kevin Nelson (Neenah, WI); David Busche (Neenah, WI); David Lynn (Middleton, WI)
Assignees: Wisconsin Alumni Research Foundation; Bemis Company, Inc.
A61L2/20A23B7/144B01J19/123B32B1/02B32B7/02B32B7/12B32B15/08B32B15/082B32B15/085B32B15/20B32B27/08B32B27/18B32B27/20B32B27/28B32B27/30B32B27/304B32B27/306B32B27/32B32B27/322B32B27/34B32B27/36B65D1/00B65D65/40B65D81/24C01B11/024C08K3/24C08L23/12A61L2202/11B01J2219/0879B01J2219/1203B32B2255/10B32B2255/20B32B2255/205B32B2264/10B32B2307/40B32B2307/50B32B2307/71B32B2307/7242B32B2307/7244B32B2307/7246B32B2307/732B32B2307/748B32B2315/00B32B2323/10B32B2405/00B32B2439/06B32B2439/46B32B2439/70B32B2439/80C08L2203/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,071,801
App. No.
15/433,510
Granted
Jul 27, 2021
Kind
B2
Abstract

A multilayer medical packaging film includes a first layer and a chlorine dioxide-producing layer. The chlorine dioxide-producing layer includes a polymer composition and a plurality of chlorite ions. The chlorine dioxide-producing layer is substantially free of an energy-activated catalyst and is substantially free of an acid-releasing compound. However, the film is capable of generating chlorine dioxide when exposed to UV light and moisture.

Claims (30)

1. A multilayer medical packaging film comprising:

a first layer, and

a chlorine dioxide-producing layer comprising a polymer composition and a source of a plurality of chlorite ions;

wherein the chlorine dioxide-producing layer comprises less than 2% by weight of an energy-activated catalyst and comprises no acid-releasing compound, wherein the weight ratio of the energy-activated catalyst to the source of the plurality of chlorite ions is 1:20 or less, and

wherein the chlorine dioxide-producing layer produces a sufficient amount of chlorine dioxide when exposed to UV light and moisture to disinfect or sterilize a medical device packaged in the film.

2. The multilayer medical packaging film according to claim 1 , wherein the source of the plurality of chlorite ions comprises a salt selected from the group consisting of sodium chlorite, potassium chlorite, and mixtures thereof.

3. The multilayer medical packaging film according to claim 1 , wherein the first layer is an oxygen barrier layer; wherein the oxygen barrier layer comprises aluminum foil, metal coated polymer, metal oxide coated polymer, or an aromatic polyamide polymer.

4. The multilayer medical packaging film according to claim 1 , wherein the first layer is an oxygen barrier layer; wherein the oxygen barrier layer comprises ethylene vinyl alcohol copolymer, polyvinylidene chloride copolymer, or an aliphatic polyamide.

5. The multilayer medical packaging film according to claim 1 , wherein the chlorine-dioxide-producing layer is a coating having a thickness less than 15 μm.

6. The multilayer medical packaging film according to claim 5 , wherein the polymer composition comprises at least one of polyethylene, ethylene vinyl acetate, ethylene alpha-olefins, or polypropylene.

7. The multilayer medical packaging film according to claim 5 , wherein the source of the plurality of chlorite ions comprises a salt, and the salt is present in an amount within a range from 0.1 weight percent to 30 weight percent relative to the total weight of the chlorine dioxide-producing layer.

8. The multilayer medical packaging film according to claim 5 , wherein the source of the plurality of chlorite ions comprises a salt, and the salt is present in an amount within a range from 10 weight percent to 20 weight percent relative to the total weight of the chlorine dioxide-producing layer.

9. The multilayer medical packaging film according to claim 1 , wherein the chlorine dioxide-producing layer has a thickness of at least 25 μm.

10. The multilayer medical packaging film according to claim 9 , wherein the polymer composition comprises at least one of polyethylene, ethylene vinyl acetate, ethylene alpha-olefins, or polypropylene.

11. The multilayer medical packaging film according to claim 9 , wherein the source of the plurality of chlorite ions comprises a salt, wherein the salt is present in an amount within a range from 0.1 weight percent to 25 weight percent relative to the total weight of the chlorine dioxide-producing layer.

12. The multilayer medical packaging film according to claim 9 , wherein the source of the plurality of chlorite ions comprises a salt, wherein the salt is present in an amount within a range from 5 weight percent to 20 weight percent relative to the total weight of the chlorine dioxide-producing layer.

13. The multilayer medical packaging film according to claim 1 , wherein the first layer is an outer layer proximate the chlorine dioxide-producing layer, wherein the outer layer comprises at least one of polyethylene or polypropylene.

14. The multilayer medical packaging film according to claim 1 , wherein the first layer is an abuse-resistant layer, wherein the abuse-resistant layer is UV-light transparent.

15. The multilayer medical packaging film according to claim 1 , wherein the film has a layer composition in the following sequence:

a layer of polyethylene;

the chlorine dioxide-producing layer;

a tie layer;

the first layer comprising an oxygen barrier layer;

a tie layer; and

an abuse layer,

wherein optional additional layers may be dispersed within said sequence.

16. A medical package comprising a sidewall comprising the multilayer medical packaging film according to claim 1 , wherein the medical package comprises an interior volume defined by an inside surface of the sidewall.

17. The medical package according to claim 16 , wherein the chlorine dioxide-producing layer is proximate the inside surface of the sidewall.

18. The medical package according to claim 16 , wherein the chlorine dioxide-producing layer has a surface area smaller than the inside surface of the sidewall.

19. The multilayer medical packaging film of claim 1 , wherein the chlorine dioxide-producing layer comprises no energy-activated catalyst.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2018
From: LYNN, DAVID; ABBOTT, NICHOLAS
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 045515/0269 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2018
From: JAIN, RISHABH
To: WISCONSIN ALUMNI RESEARCH FOUNDATION; BEMIS COMPANY INC.
Reel/Frame 045515/0459 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2017
From: NELSON, KEVIN P.; BUSCHE, DAVID
To: BEMIS COMPANY, INC.
Reel/Frame 042574/0361 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2017
From: LYNN, DAVID; ABBOTT, NICHOLAS
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 042574/0384 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2017
From: JAIN, RISHABH
To: BEMIS COMPANY, INC.
Reel/Frame 042672/0425 →
Continuity (3)
Continuation PCTUS2015047608 · Aug 18, 2016
Provisional Application 62206464 · Aug 18, 2015
Related Publication 20170157904A1 · Jun 8, 2017
Cited By (2)
US 12,654,909 US 12,660,827